CHRONIC APOCYNIN TREATMENT IMPROVES NORADRENERGIC PRESYNAPTIC REUPTAKE, INHIBITS SYMPATHETIC-MEDIATED LIPOLYSIS AND FAT LOSS IN A AGING RAT MODEL OF HEART FAILURE